Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Roche inks $200M pact for Freenome's cancer screening blood test - Fierce Biotech
Roche inks $200M pact for Freenome's cancer screening blood test Fierce Biotech